X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7013) 7013
Publication (570) 570
Book Review (175) 175
Newsletter (159) 159
Magazine Article (57) 57
Book Chapter (25) 25
Newspaper Article (21) 21
Conference Proceeding (20) 20
Trade Publication Article (14) 14
Book / eBook (8) 8
Web Resource (7) 7
Data Set (6) 6
Dissertation (3) 3
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4126) 4126
proton pump inhibitors (3844) 3844
pharmacology & pharmacy (3132) 3132
index medicus (2688) 2688
male (2276) 2276
female (1820) 1820
animals (1678) 1678
omeprazole (1593) 1593
gastroenterology & hepatology (1317) 1317
adult (1250) 1250
middle aged (1250) 1250
aged (986) 986
proton pump inhibitor (975) 975
lansoprazole (958) 958
hydrogen-ion concentration (861) 861
proton pump inhibitors - therapeutic use (805) 805
proton pump inhibitors - pharmacology (719) 719
omeprazole - pharmacology (671) 671
2-pyridinylmethylsulfinylbenzimidazoles (670) 670
enzyme inhibitors - pharmacology (655) 655
rats (639) 639
gastroesophageal reflux - drug therapy (613) 613
omeprazole - analogs & derivatives (605) 605
treatment outcome (593) 593
pharmacokinetics (589) 589
drug interactions (585) 585
anti-ulcer agents - therapeutic use (570) 570
helicobacter infections - drug therapy (543) 543
protons (528) 528
rabeprazole (519) 519
anti-ulcer agents - pharmacology (515) 515
risk factors (514) 514
research (503) 503
helicobacter pylori (499) 499
biochemistry & molecular biology (488) 488
therapy (486) 486
proton pump inhibitors - adverse effects (478) 478
pantoprazole (477) 477
gastroesophageal reflux (475) 475
drug therapy, combination (468) 468
proton pump inhibitors - administration & dosage (463) 463
medicine & public health (423) 423
omeprazole - therapeutic use (411) 411
drug therapy (410) 410
dose-response relationship, drug (409) 409
pharmacology (408) 408
risk (402) 402
pharmacology/toxicology (396) 396
aged, 80 and over (392) 392
gastroesophageal-reflux disease (392) 392
esomeprazole (370) 370
adolescent (364) 364
anti-bacterial agents - pharmacology (358) 358
double-blind (354) 354
time factors (349) 349
care and treatment (347) 347
health aspects (347) 347
proton-pump inhibitors (347) 347
drugs (330) 330
helicobacter pylori - drug effects (328) 328
internal medicine (328) 328
young adult (315) 315
mice (314) 314
omeprazole - administration & dosage (313) 313
anti-ulcer agents - administration & dosage (312) 312
cell biology (310) 310
analysis (301) 301
clopidogrel (290) 290
metabolism (288) 288
physiology (279) 279
atpase (276) 276
gastric acid - secretion (276) 276
dosage and administration (275) 275
anti-bacterial agents - therapeutic use (274) 274
gastroesophageal reflux disease (274) 274
proton pump (271) 271
cross-over studies (270) 270
physiological aspects (266) 266
cytochrome p-450 cyp2c19 (261) 261
administration, oral (260) 260
article (259) 259
helicobacter-pylori infection (256) 256
disease (255) 255
infection (254) 254
gastric mucosa - drug effects (251) 251
h-k (251) 251
benzimidazoles - pharmacology (250) 250
retrospective studies (245) 245
double-blind method (244) 244
management (243) 243
kinetics (242) 242
ticlopidine - analogs & derivatives (240) 240
proton-translocating atpases - antagonists & inhibitors (239) 239
rats, sprague-dawley (238) 238
cancer (237) 237
chemistry, medicinal (235) 235
complications and side effects (235) 235
nonsteroidal antiinflammatory drugs (235) 235
toxicology (235) 235
proton-translocating atpases - metabolism (231) 231
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7063) 7063
Japanese (77) 77
French (40) 40
Spanish (36) 36
Russian (32) 32
German (25) 25
Chinese (10) 10
Dutch (5) 5
Korean (5) 5
Polish (5) 5
Italian (4) 4
Portuguese (3) 3
Hungarian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Danish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Gastroenterology Reports, ISSN 1522-8037, 12/2008, Volume 10, Issue 6, pp. 528 - 534
The gastric H,K-ATPase is the primary target for the treatment of acid-related diseases. Proton pump inhibitors (PPIs) are weak bases composed of two moieties,... 
Medicine & Public Health | Gastroenterology | Gastroesophageal reflux | Proton pump inhibitors | Pyridine | Adenosine triphosphatase
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 845 - 853
BACKGROUND—Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely prescribed for the treatment of gastroesophageal reflux disease. Recently,... 
dimethylarginine dimethylaminohydrolase | endothelium | proton pump inhibitors | nitric oxide | N,N dimethylarginine | N dimethylarginine | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | ENDOTHELIAL DYSFUNCTION | MYOCARDIAL-INFARCTION | NITRIC-OXIDE SYNTHASE | ACID SUPPRESSION | ADMA | DIMETHYLAMINOHYDROLASE DDAH | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | STAGE RENAL-DISEASE | ARTERY-DISEASE | Proton Pump Inhibitors - pharmacology | Humans | Esomeprazole - adverse effects | Esomeprazole - pharmacology | Endothelium, Vascular - drug effects | Male | Arginine - analogs & derivatives | Esomeprazole - therapeutic use | Cardiovascular Diseases - epidemiology | Nitric Oxide Synthase Type III - metabolism | Gastroesophageal Reflux - drug therapy | Disease Models, Animal | Amidohydrolases - metabolism | Proton Pump Inhibitors - adverse effects | Cardiovascular Diseases - metabolism | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Biomarkers - blood | Proton Pump Inhibitors - therapeutic use | Animals | Lansoprazole - adverse effects | Endothelium, Vascular - metabolism | Arginine - blood | Lansoprazole - pharmacology | Endothelium, Vascular - pathology | Mice | Vasodilation - drug effects | Lansoprazole - therapeutic use | Gastroesophageal reflux | Complications and side effects | Usage | Care and treatment | Patient outcomes | Proton pump inhibitors | Cardiovascular diseases | Drug therapy | Health aspects | Risk factors
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects
Journal Article
Journal Article
Journal Article